← Back to Search

Lifestyle Intervention for Type 2 Diabetes (LIBERATE Trial)

N/A
Recruiting
Led By Sonja M Reichert, MD
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Naïve to Flash glucose monitors BUT interested in using this technology
Diagnosis of Type 2 diabetes, age >18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

LIBERATE Trial Summary

This trialwill test a 6-month program, with bi-weekly group classes and weekly communication, to help people with diabetes manage their health through nutrition and exercise.

Who is the study for?
This trial is for adults over 18 with Type 2 diabetes who have internet access, an email address, a compatible smartphone, and are new to using Flash glucose monitors. They must be cleared by a physician to exercise and have an HbA1c level of at least 8.0%. Pregnant individuals or those unable to safely exercise or fully participate in the program are excluded.Check my eligibility
What is being tested?
The LIBERATE intervention includes fitness testing, wearable technology (FitBit Inspire 2™ and FreeStyle® Libre sensors) for monitoring glucose levels and activity, bi-weekly then monthly virtual group classes on nutrition and exercise, with optional individualized training prescriptions. The goal is to reduce A1c levels through lifestyle changes.See study design
What are the potential side effects?
While this study focuses on lifestyle interventions rather than medications, potential side effects may include discomfort from wearing devices or injury from increased physical activity if not properly monitored.

LIBERATE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have never used a Flash glucose monitor but want to try it.
Select...
I am over 18 and have been diagnosed with Type 2 diabetes.

LIBERATE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HbA1c from Baseline
Secondary outcome measures
Change in rapid insulin use from Baseline
Change in total daily basal insulin use from baseline
Other outcome measures
Anthropometric: Change in Height from baseline
Anthropometric: Change in Waist circumference from baseline
Anthropometric: Change in Weight from baseline
+19 more

LIBERATE Trial Design

1Treatment groups
Experimental Treatment
Group I: LIBERATE InterventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Abbott Diabetes CareIndustry Sponsor
63 Previous Clinical Trials
24,557 Total Patients Enrolled
Western University, CanadaLead Sponsor
239 Previous Clinical Trials
57,299 Total Patients Enrolled
Sonja M Reichert, MDPrincipal InvestigatorWestern University

Media Library

LIBERATE Clinical Trial Eligibility Overview. Trial Name: NCT05261906 — N/A
Type 2 Diabetes Research Study Groups: LIBERATE Intervention
Type 2 Diabetes Clinical Trial 2023: LIBERATE Highlights & Side Effects. Trial Name: NCT05261906 — N/A
LIBERATE 2023 Treatment Timeline for Medical Study. Trial Name: NCT05261906 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study still recruiting participants?

"Affirmative. Clinicaltrials.gov's records inform us that the enrollment window for this clinical trial is open, and it was first posted on September 26th 2022 before being updated on October 7th 2022. 184 participants are required from 1 site to complete the study."

Answered by AI

What is the maximum number of enrollees for this scientific investigation?

"Affirmative. Data provided on clinicaltrials.gov says that this research project is currently requiring participants, with the first posting occuring on September 26th 2022 and last amendment happening October 7th 2022. In total, 184 people are being welcomed at 1 site for participation in this study."

Answered by AI
~92 spots leftby Oct 2025